BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11559997)

  • 21. [Effect of plant biocomposites based on Georgian tea "per se" and in combination with cisplatin on Walker carcinosarcoma W-256 and Guerin's carcinoma growth rate in rats].
    Zalietok SP; Orlovs'kyĭ OA; Hohol' SV; Samoĭlenko OA; Hulua L; Kvesitadze HI
    Lik Sprava; 2006 Dec; (8):89-93. PubMed ID: 17427433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
    Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS
    Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The efficacy of the multienzyme preparation Wobe-Mugos E in lymphoproliferative diseases].
    Kolomoiets' MIu; Antofiĭchuk MP
    Lik Sprava; 1999 Jun; (4):150-4. PubMed ID: 10476670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of proteolytic enzymes (trypsin, chymotrypsin, streptokinase, streptodornase, papain) in stomatology].
    Protasevich AI
    Stomatologiia (Mosk); 1967; 46(5):107-9. PubMed ID: 4863251
    [No Abstract]   [Full Text] [Related]  

  • 25. The antineoplastic activity of 4'-deoxydoxorubicin in murine solid tumors.
    Marmonti L; Jin XQ; Filippeschi S; Spreafico F
    Anticancer Res; 1984; 4(6):425-9. PubMed ID: 6517535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frederine, a new and promising protector against doxorubicin-induced cardiotoxicity.
    van Acker FA; Boven E; Kramer K; Haenen GR; Bast A; van der Vijgh WJ
    Clin Cancer Res; 2001 May; 7(5):1378-84. PubMed ID: 11350909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antitumor activity and toxicity of combined doxorubicin and disodium salt of methylene-1,1-diphosphonic acid].
    Stukov AN; Mironiuk TN; Kon'kov SA; Krylova IM; Reztsova VV; Filov VA; Ivin BA
    Vopr Onkol; 1998; 44(1):100-2. PubMed ID: 9578741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.
    Seymour L; Bramwell V; Moran LA
    Cancer Prev Control; 1999 Apr; 3(2):145-59. PubMed ID: 10474762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrphostin 4-nitrobenzylidene malononitrile reduces chemotherapy toxicity without impairing efficacy.
    Novogrodsky A; Weisspapir M; Patya M; Meshorer A; Vanichkin A
    Cancer Res; 1998 Jun; 58(11):2397-403. PubMed ID: 9622080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of enzymes on malignant tumors].
    Oleĭnik II
    Vopr Onkol; 1966; 12(11):104-9. PubMed ID: 4886755
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of liposomal antitumor preparation 5,6-benzocoumarin-5-uracil on intensity of free-radical processes in the liver microsomes and tumor cells of rats with transplanted Guerin's carcinoma].
    Marchenko MM; Ketsa OV
    Ukr Biokhim Zh (1999); 2005; 77(2):141-6. PubMed ID: 16335247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute circulatory shock following administration of the non-regular enzyme preparation Wobe-Mugos].
    de Smet PA; Pegt GW; Meyboom RH
    Ned Tijdschr Geneeskd; 1991 Dec; 135(49):2341-4. PubMed ID: 1809893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice.
    Feleszko W; Mlynarczuk I; Balkowiec-Iskra EZ; Czajka A; Switaj T; Stoklosa T; Giermasz A; Jakóbisiak M
    Clin Cancer Res; 2000 May; 6(5):2044-52. PubMed ID: 10815931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of vitamin A provision on antineoplastic resistance in rats].
    Marchenko MM; Shmarakov IA; Pasaĭliuk MV
    Vopr Pitan; 2008; 77(6):4-8. PubMed ID: 19227855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trastuzumab and doxorubicin-related cardiotoxicity and the cardioprotective role of exercise.
    Wonders KY; Reigle BS
    Integr Cancer Ther; 2009 Mar; 8(1):17-21. PubMed ID: 19174506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dynamics of rat blood serum biochemical parameters under malignant growth in condition of the antioxidant substance "greenization green R" introduction].
    Raetskaia IaB; Ishchuk TV; Ostapchenko LI
    Biomed Khim; 2013; 59(6):693-9. PubMed ID: 24511681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardioprotective activity of standardized extract of Ficus racemosa stem bark against doxorubicin-induced toxicity.
    Ahmed F; Urooj A
    Pharm Biol; 2012 Apr; 50(4):468-73. PubMed ID: 22136326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats.
    Puri A; Maulik SK; Ray R; Bhatnagar V
    Eur J Pediatr Surg; 2005 Dec; 15(6):387-91. PubMed ID: 16418954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Histone specific proteinase and DNase activity of spleen lymphocyte nuclei during oncogenesis and under the effect of hydrobromide-5-(5',6' benzocoumaroyl-3')-methylaminouracil].
    Kopyl'chuk HP; Marchenko MM; Iakovyshyn HV
    Ukr Biokhim Zh (1999); 2008; 80(1):40-5. PubMed ID: 18710025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of the use of an oral trypsin-chymotrypsin combination in gynecologic therapy].
    Tozzi T; Lauda N
    Minerva Ginecol; 1972; 24(8):405-9. PubMed ID: 4603804
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.